Eversept Partners, LP Sutro Biopharma, Inc. Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
A detailed history of Eversept Partners, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 2,292,261 shares of STRO stock, worth $1.97 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,292,261
Previous 694,408
230.1%
Holding current value
$1.97 Million
Previous $1.28 Million
16.6%
% of portfolio
0.16%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding STRO
# of Institutions
119Shares Held
60.5MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.42 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$5.94 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.68 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$3.81 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$3.78 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $44.9M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...